• DeepMind’s CEO, Demis Hassabis, predicts that advancements in artificial intelligence could significantly reduce the drug discovery timeline from several years to just months.
  • This breakthrough aims to address the high failure rates that currently plague the pharmaceutical industry.
  • The implications of such a shift could lead to faster development of new medicines, potentially transforming healthcare outcomes.

Source: bloomberg.com